156 related articles for article (PubMed ID: 1722803)
1. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene.
Hayashi S; Watanabe J; Nakachi K; Kawajiri K
J Biochem; 1991 Sep; 110(3):407-11. PubMed ID: 1722803
[TBL] [Abstract][Full Text] [Related]
2. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
[TBL] [Abstract][Full Text] [Related]
3. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
Hamada GS; Sugimura H; Suzuki I; Nagura K; Kiyokawa E; Iwase T; Tanaka M; Takahashi T; Watanabe S; Kino I
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):63-7. PubMed ID: 7534543
[TBL] [Abstract][Full Text] [Related]
4. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene.
Kawajiri K; Nakachi K; Imai K; Yoshii A; Shinoda N; Watanabe J
FEBS Lett; 1990 Apr; 263(1):131-3. PubMed ID: 1691986
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
6. MspI polymorphism of the human CYP2E gene.
Uematsu F; Kikuchi H; Abe T; Motomiya M; Ohmachi T; Sagami I; Watanabe M
Nucleic Acids Res; 1991 Oct; 19(20):5797. PubMed ID: 1719479
[No Abstract] [Full Text] [Related]
7. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes.
Hayashi S; Watanabe J; Kawajiri K
Jpn J Cancer Res; 1992 Aug; 83(8):866-70. PubMed ID: 1399823
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene.
Hayashi S; Watanabe J; Kawajiri K
J Biochem; 1991 Oct; 110(4):559-65. PubMed ID: 1778977
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil.
Sugimura H; Hamada GS; Suzuki I; Iwase T; Kiyokawa E; Kino I; Tsugane S
Pharmacogenetics; 1995; 5 Spec No():S145-8. PubMed ID: 7581485
[TBL] [Abstract][Full Text] [Related]
10. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.
Pastorelli R; Guanci M; Cerri A; Negri E; La Vecchia C; Fumagalli F; Mezzetti M; Cappelli R; Panigalli T; Fanelli R; Airoldi L
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):703-9. PubMed ID: 9718223
[TBL] [Abstract][Full Text] [Related]
11. Two MspI polymorphisms within the APC gene.
Cottrell S; Bodmer WF
Hum Mol Genet; 1992 Aug; 1(5):352. PubMed ID: 1284630
[No Abstract] [Full Text] [Related]
12. PCR detection of the MspI (Aa) RFLP at the human phenylalanine hydroxylase (PAH) locus.
Wedemeyer N; Dworniczak B; Horst J
Nucleic Acids Res; 1991 Apr; 19(8):1959. PubMed ID: 1709499
[No Abstract] [Full Text] [Related]
13. Human gastric cathepsin E gene. Multiple transcripts result from alternative polyadenylation of the primary transcripts of a single gene locus at 1q31-q32.
Azuma T; Liu WG; Vander Laan DJ; Bowcock AM; Taggart RT
J Biol Chem; 1992 Jan; 267(3):1609-14. PubMed ID: 1370478
[TBL] [Abstract][Full Text] [Related]
14. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population.
Hirvonen A; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Vainio H
Carcinogenesis; 1993 Jan; 14(1):85-8. PubMed ID: 8093864
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis in cystic fibrosis using the amplification refractory mutation system (ARMS): the J3.11 MspI polymorphism.
Newton CR; Summers C; Heptinstall LE; Lynch JR; Finniear RS; Ogilvie D; Smith JC; Markham AF
J Med Genet; 1991 Apr; 28(4):248-51. PubMed ID: 1713272
[TBL] [Abstract][Full Text] [Related]
16. Identification of the primary gene defect at the cytochrome P450 CYP2D locus.
Gough AC; Miles JS; Spurr NK; Moss JE; Gaedigk A; Eichelbaum M; Wolf CR
Nature; 1990 Oct; 347(6295):773-6. PubMed ID: 1978251
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning.
Wetmur JG; Kaya AH; Plewinska M; Desnick RJ
Am J Hum Genet; 1991 Oct; 49(4):757-63. PubMed ID: 1716854
[TBL] [Abstract][Full Text] [Related]
18. Polymerase chain reaction for detection of the pMP6d-9/MspI RFLP, a marker closely linked to the cystic fibrosis mutation.
Huth A; Estivill X; Grade K; Billwitz H; Speer A; Rosenthal A; Williamson R; Ramsay M; Coutelle C
Nucleic Acids Res; 1989 Sep; 17(17):7118. PubMed ID: 2476727
[No Abstract] [Full Text] [Related]
19. Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer.
Hirvonen A; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Vainio H
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):109-12. PubMed ID: 7908263
[TBL] [Abstract][Full Text] [Related]
20. The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin.
Barsky SH; Grossman DA; Ho J; Holmes EC
Mod Pathol; 1994 Aug; 7(6):633-40. PubMed ID: 7527541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
